Detalhe da pesquisa
1.
Late renal toxicity in patient with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib: A case report and literature review.
J Oncol Pharm Pract
; 28(8): 1930-1935, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35369811
2.
Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia.
Hematology
; 28(1): 2237342, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37485976
3.
An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease.
Hematology
; 28(1): 2215575, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227254
4.
Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review.
Hematol Rep
; 14(1): 45-53, 2022 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323179
5.
Successful Treatment of Autoimmune Hemolytic Anemia Concomitant with Proliferation of Epstein-Barr Virus in a Post-Heart Transplant Patient.
Hematol Rep
; 14(3): 261-264, 2022 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997403
6.
Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature.
Pathol Oncol Res
; 28: 1610588, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091937
7.
Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products.
Biomedicines
; 10(6)2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740430
8.
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis.
Clin Lung Cancer
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744613